MEYERS STEVE LAWRENCE enters OCULAR THERAPEUTIX, INC with 152.73K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 6/23/2025ACC: 0001104659-25-061850
Officer· Chief Commercial Officer
Since Jun 2025
152.73K
Baseline shares
100% direct
152.73K
Direct ownership
1 position
512K
Derivative underlying
4 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned152.73K
Total
152.73K direct152.73K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 152.73K | Direct |
| Total | 152.73K | 152.73K direct |
Derivative Holdings4
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
45K
Shares owned
N/A
Exercise price
5.22
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
100K
Shares owned
N/A
Exercise price
3.88
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
145K
Shares owned
N/A
Exercise price
5.18
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
222K
Shares owned
N/A
Exercise price
7.44
Expiration
—
Exercise window
—
Total
Underlying
512K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 5.22 | — | — | 45K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 3.88 | — | — | 100K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 5.18 | — | — | 145K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 7.44 | — | — | 222K | N/A |
| Total | 512K | 0.00 | ||||